Welcome to another working week. We hope the weekend was refreshing and relaxing because the familiar routine of meetings and deadlines and what-not is now officially under way. To cope, yes, we are grasping a cup of stimulation and invite you to join us. After all, there is much to do. We trust you can relate. Meanwhile, here is the latest menu of tidbits to help you get started. Hope your day goes well and do stay in touch...
Novartis To Create 100 New Jobs In Dublin (RTE News)
Bristol-Myers Promotes Cuss To R&D Chief (Reuters)
Saudi Arabis Warns Against Unauthorized Social Media Ads (Arab News)
Merck Starts A New Trial Over Fosamax Damage (Bloomberg News)
Florida Mulls Biosimilar Legislation (Gainesville Sun)
Orphan Drug Prices Under Siege In Europe (Bloomberg News)
Bristol-Myers And Vertex Strike Hep C Pact (Pharma Times)
Lundbeck Antidepressant Gets Boost From Clinical Trial (Reuters)
Price Cap In India Will Lower Cancer Drug Prices (Hindustan Times)
Bristol-Myers To Cut 300 Amylin Jobs (Associated Press)
Nexterone Linked To Increased Cancer Risk In Men (MedPage Today)
Covis Buys Rights To Five Sanofi Drugs (Drug Store News)
EDITOR'S NOTE: Please check this post for additional stories during the day
steaming coffee pic thx to dleggett on flickr